XR-17 is Oasmia’s proprietary delivery platform

CEO corner

Get to learn more about Francois Martelet, our CEO

Oasmia Pharmaceutical published its Q1 report on September 9, 2020, at 08.00 am CEST.

The Share

Oasmia and Elevar sign a global strategic partnership for the commercialization of Apealea®

Annual Report 2019 / 2020